This company is no longer active
Bu sayfanın çevirisi deneyseldir ve geliştirilme aşamasındadır. imlerinizi bekliyoruz!
Tricida Yönetim
Yönetim kriter kontrolleri 3/4
Tricida's CEO is Gerrit Klaerner, appointed in Aug 2013, they has a tenure of 9.83 years. Their total yearly compensation is $4.68M , comprised of 12.8% salary and 87.2% bonuses, including company stock and options. They directly owns 0.68% of the company’s shares, worth $3.93. The average tenure of the management team and the board of directors is 4 years and 9.5 years respectively.
Anahtar bilgiler
Gerrit Klaerner
İcra Kurulu Başkanı
US$4.7m
Toplam tazminat
CEO maaş yüzdesi | 12.8% |
CEO görev süresi | 9.8yrs |
CEO sahipliği | 0.7% |
Yönetim ortalama görev süresi | 4yrs |
Yönetim Kurulu ortalama görev süresi | 9.5yrs |
Son yönetim güncellemeleri
Recent updates
Tricida enters $125M debt facility
Oct 19Tricida: Important Binary Event Coming Up
Sep 21Calculating The Intrinsic Value Of Tricida, Inc. (NASDAQ:TCDA)
Sep 14Insider Buying: The Tricida, Inc. (NASDAQ:TCDA) CFO & Executive VP Just Bought 6.5% More Shares
Dec 14Tricida revises VALOR-CKD trial protocol, updates patent protection, shares down 14%
Dec 09Tricida's Veverimer CRL And Regulatory Updates: An Analysis
Nov 17Tricida slumps 46% on FDA feedback on veverimer proposal; launches cost-cutting initiatives
Oct 29CEO Tazminat Analizi
Tarih | Toplam Tazminat | Maaş | Şirket Kazançları |
---|---|---|---|
Sep 30 2022 | n/a | n/a | -US$134m |
Jun 30 2022 | n/a | n/a | -US$148m |
Mar 31 2022 | n/a | n/a | -US$153m |
Dec 31 2021 | US$5m | US$600k | -US$177m |
Sep 30 2021 | n/a | n/a | -US$181m |
Jun 30 2021 | n/a | n/a | -US$219m |
Mar 31 2021 | n/a | n/a | -US$244m |
Dec 31 2020 | US$9m | US$598k | -US$265m |
Sep 30 2020 | n/a | n/a | -US$268m |
Jun 30 2020 | n/a | n/a | -US$235m |
Mar 31 2020 | n/a | n/a | -US$213m |
Dec 31 2019 | US$10m | US$584k | -US$177m |
Sep 30 2019 | n/a | n/a | -US$146m |
Jun 30 2019 | n/a | n/a | -US$131m |
Mar 31 2019 | n/a | n/a | -US$120m |
Dec 31 2018 | US$1m | US$503k | -US$103m |
Sep 30 2018 | n/a | n/a | -US$96m |
Jun 30 2018 | n/a | n/a | -US$77m |
Mar 31 2018 | n/a | n/a | -US$60m |
Dec 31 2017 | US$821k | US$425k | -US$41m |
Tazminat ve Piyasa: Gerrit's total compensation ($USD4.68M) is above average for companies of similar size in the US market ($USD747.42K).
Tazminat ve Kazançlar: Gerrit's compensation has been consistent with company performance over the past year.
CEO
Gerrit Klaerner (51 yo)
9.8yrs
Görev süresi
US$4,676,490
Tazminat
Dr. Gerrit Klaerner, Ph.D. Founded Tricida, Inc.and has been its Chief Executive Officer and President since August 2013 and has been its an Executive Director since July 2013. Dr. Klaerner was the Founder...
Liderlik Ekibi
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
Founder | 9.8yrs | US$4.68m | 0.68% $ 3.9 | |
COO, CFO & Executive VP | 6.2yrs | US$2.51m | 0.72% $ 4.2 | |
Executive VP | 3.3yrs | US$2.43m | 0.031% $ 0.2 | |
Executive Vice President of Clinical Development | 4.8yrs | US$2.77m | 0.0060% $ 0.03 | |
VP of Finance & Chief Accounting Officer | 2.5yrs | Veri yok | Veri yok | |
Vice President of Investor Relations & Communications | no data | Veri yok | Veri yok | |
Executive Vice President of Intellectual Property | 3.3yrs | US$2.10m | Veri yok |
4.0yrs
Ortalama Görev Süresi
58yo
Ortalama Yaş
Deneyimli Yönetim: TCDA.Q's management team is considered experienced (4 years average tenure).
Yönetim Kurulu Üyeleri
İsim | Pozisyon | Görev süresi | Tazminat | Sahiplik |
---|---|---|---|---|
Founder | 9.9yrs | US$4.68m | 0.68% $ 3.9 | |
Independent Non-Employee Director | 5.1yrs | US$329.00k | 0.074% $ 0.4 | |
Independent Chairman of the Board | 9.3yrs | US$379.00k | 0.20% $ 1.1 | |
Independent Non-Employee Director | 6.9yrs | US$326.50k | 0.019% $ 0.1 | |
Independent Non-Employee Director and Member of Scientific & Clinical Advisory Board | 9.7yrs | US$314.00k | Veri yok | |
Member of Scientific & Clinical Advisory Board | no data | Veri yok | Veri yok | |
Member of Scientific & Clinical Advisory Board | no data | Veri yok | Veri yok | |
Member of Scientific & Clinical Advisory Board | no data | Veri yok | Veri yok | |
Independent Non-Employee Director and Member of Scientific & Clinical Advisory Board | 9.9yrs | US$316.50k | 0.15% $ 0.9 | |
Member of Scientific & Clinical Advisory Board | no data | Veri yok | Veri yok | |
Member of Scientific & Clinical Advisory Board | no data | Veri yok | Veri yok | |
Member of Scientific and Clinical Advisory Board | no data | Veri yok | Veri yok |
9.5yrs
Ortalama Görev Süresi
60yo
Ortalama Yaş
Deneyimli Yönetim Kurulu: TCDA.Q's board of directors are considered experienced (9.5 years average tenure).